127 results
8-K
BCRX
Biocryst Pharmaceuticals Inc.
4 Jan 13
Departure of Directors or Certain Officers
12:00am
on January 1, 2013 consisting of stock options and shares of restricted stock to all eligible employees as a retention incentive (the “2013 Retention Grant … ”). The amount of the 2013 Retention Grant with respect to each employee was the number of stock options and shares of restricted stock granted
10-K/A
2009 FY
BCRX
Biocryst Pharmaceuticals Inc.
19 Jan 11
Annual report (amended)
12:00am
of the following four elements:
base salary;
annual incentive compensation;
special retention incentives and stock option grants;
long-term equity incentive … , increasing their annual incentive bonus target to 30% of annual base salary.
Special Retention Incentives
In May 2008, the Committee approved
8-K
EX-99.1
fw40l kl2nmn
3 Nov 21
BioCryst Reports Third Quarter 2021 Financial Results and Upcoming Key Milestones
7:04am
8-K
EX-99.1
3wzoag
5 Aug 21
BioCryst Reports Second Quarter 2021 Financial Results and Upcoming Key Milestones
7:06am
DEFA14A
2hglrugucxq088u31
26 May 22
Additional proxy soliciting materials
5:00pm
425
h5mfo43opreeja
8 May 18
Business combination disclosure
3:14pm
425
3fjk5i wh
8 May 18
Business combination disclosure
3:15pm
8-K
EX-99.1
suvxl2 xa
10 Jan 22
Results of Operations and Financial Condition
7:04am
425
qg6e 50155ulrvg
22 Jan 18
Business combination disclosure
12:00am
425
jh1vkgc oh3xv
22 Jan 18
Business combination disclosure
12:00am
425
njn0zppz6er
22 Jan 18
Business combination disclosure
12:00am
425
krspb1k 43u1sf9q
9 May 18
Business combination disclosure
6:35am
425
v804f6 qpbk25w
7 Jun 18
Business combination disclosure
8:15am
425
9kq8lhnn sw
7 Jun 18
Business combination disclosure
8:17am
425
lz6uxh3e81pmpv
22 Oct 12
Business combination disclosure
12:00am